Janux Begin Period Cash Flow vs Investments Analysis

JANX Stock  USD 56.83  0.08  0.14%   
Janux Therapeutics financial indicator trend analysis is infinitely more than just investigating Janux Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Janux Therapeutics is a good investment. Please check the relationship between Janux Therapeutics Begin Period Cash Flow and its Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

Begin Period Cash Flow vs Investments

JavaScript chart by amCharts 3.21.152014201620182020202220245M10M15M20M25M30M35M40M45M50M55M -300M-250M-200M-150M-100M-50M050M
JavaScript chart by amCharts 3.21.15Begin Period Cash Flowtotal: 155.4MInvestmentstotal: -3.1B

Begin Period Cash Flow vs Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Janux Therapeutics Begin Period Cash Flow account and Investments. At this time, the significance of the direction appears to have almost identical trend.
Begin Period Cash FlowInvestmentsDiversified AwayBegin Period Cash FlowInvestmentsDiversified Away100%
The correlation between Janux Therapeutics' Begin Period Cash Flow and Investments is 0.92. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Investments in the same time period over historical financial statements of Janux Therapeutics, assuming nothing else is changed. The correlation between historical values of Janux Therapeutics' Begin Period Cash Flow and Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Janux Therapeutics are associated (or correlated) with its Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Investments has no effect on the direction of Begin Period Cash Flow i.e., Janux Therapeutics' Begin Period Cash Flow and Investments go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.
Most indicators from Janux Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Janux Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.At this time, Janux Therapeutics' Issuance Of Capital Stock is fairly stable compared to the past year. Enterprise Value is likely to rise to about 850.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 13.5 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense370K4.0M4.6M4.9M
Depreciation And Amortization113K841K2.0M2.1M

Janux Therapeutics fundamental ratios Correlations

0.710.970.971.00.970.79-0.63-0.841.00.910.80.751.00.960.430.520.990.741.00.79-0.481.01.01.0-0.81
0.710.840.790.690.70.94-0.11-0.860.680.650.930.810.680.740.530.680.750.80.690.93-0.530.680.740.68-0.39
0.970.840.970.960.940.89-0.53-0.90.970.90.890.80.960.950.480.650.990.840.960.88-0.510.960.980.96-0.76
0.970.790.970.970.940.84-0.62-0.830.960.950.840.720.970.940.390.520.960.750.970.83-0.440.970.970.96-0.71
1.00.690.960.970.970.77-0.64-0.831.00.90.780.731.00.960.420.480.990.71.00.77-0.471.01.01.0-0.79
0.970.70.940.940.970.84-0.52-0.90.970.870.850.840.971.00.610.50.970.720.970.84-0.660.970.970.97-0.8
0.790.940.890.840.770.84-0.18-0.960.780.751.00.920.770.880.720.730.830.860.771.0-0.740.770.810.77-0.59
-0.63-0.11-0.53-0.62-0.64-0.52-0.180.16-0.62-0.78-0.180.01-0.65-0.470.29-0.22-0.57-0.38-0.63-0.15-0.22-0.65-0.59-0.650.66
-0.84-0.86-0.9-0.83-0.83-0.9-0.960.16-0.84-0.71-0.97-0.98-0.82-0.93-0.8-0.68-0.88-0.81-0.83-0.970.82-0.83-0.86-0.830.67
1.00.680.970.961.00.970.78-0.62-0.840.90.790.751.00.960.450.520.990.731.00.78-0.51.01.01.0-0.82
0.910.650.90.950.90.870.75-0.78-0.710.90.750.570.910.870.270.570.890.770.90.72-0.320.910.90.91-0.79
0.80.930.890.840.780.851.0-0.18-0.970.790.750.930.780.890.730.730.840.860.781.0-0.750.780.820.78-0.6
0.750.810.80.720.730.840.920.01-0.980.750.570.930.730.870.90.60.790.710.730.94-0.90.730.770.73-0.57
1.00.680.960.971.00.970.77-0.65-0.821.00.910.780.730.960.420.490.990.711.00.76-0.471.01.01.0-0.81
0.960.740.950.940.961.00.88-0.47-0.930.960.870.890.870.960.650.550.970.750.960.88-0.690.960.970.96-0.79
0.430.530.480.390.420.610.720.29-0.80.450.270.730.90.420.650.430.480.470.420.76-1.00.420.450.42-0.39
0.520.680.650.520.480.50.73-0.22-0.680.520.570.730.60.490.550.430.580.960.470.73-0.430.50.530.5-0.69
0.990.750.990.960.990.970.83-0.57-0.880.990.890.840.790.990.970.480.580.780.990.82-0.520.991.00.99-0.81
0.740.80.840.750.70.720.86-0.38-0.810.730.770.860.710.710.750.470.960.780.70.85-0.480.720.750.72-0.78
1.00.690.960.971.00.970.77-0.63-0.831.00.90.780.731.00.960.420.470.990.70.76-0.471.01.01.0-0.79
0.790.930.880.830.770.841.0-0.15-0.970.780.721.00.940.760.880.760.730.820.850.76-0.770.770.810.76-0.59
-0.48-0.53-0.51-0.44-0.47-0.66-0.74-0.220.82-0.5-0.32-0.75-0.9-0.47-0.69-1.0-0.43-0.52-0.48-0.47-0.77-0.47-0.5-0.480.44
1.00.680.960.971.00.970.77-0.65-0.831.00.910.780.731.00.960.420.50.990.721.00.77-0.471.01.0-0.81
1.00.740.980.971.00.970.81-0.59-0.861.00.90.820.771.00.970.450.531.00.751.00.81-0.51.01.0-0.78
1.00.680.960.961.00.970.77-0.65-0.831.00.910.780.731.00.960.420.50.990.721.00.76-0.481.01.0-0.82
-0.81-0.39-0.76-0.71-0.79-0.8-0.590.660.67-0.82-0.79-0.6-0.57-0.81-0.79-0.39-0.69-0.81-0.78-0.79-0.590.44-0.81-0.78-0.82
Click cells to compare fundamentals

Janux Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Janux Stock Analysis

When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…